PG
MRNA icon

Proffitt & Goodson’s Moderna MRNA Stock Holding History

Proffitt & Goodson’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.08K Buy
+100
New +$4.67K ﹤0.01% 256
2025
Q4 		– Sell
-150
Closed -$3.88K – 388
2025
Q3 		$3.88K Hold
150
– – ﹤0.01% 327
2025
Q2 		$4.14K Hold
150
– – ﹤0.01% 237
2025
Q1 		$4.25K Buy
+150
New +$5.32K ﹤0.01% 228
2024
Q4 		– Sell
-50
Closed -$3.34K – 290
2024
Q3 		$3.34K Hold
50
– – ﹤0.01% 252
2024
Q2 		$5.94K Hold
50
– – ﹤0.01% 240
2024
Q1 		$5.33K Hold
50
– – ﹤0.01% 208
2023
Q4 		$4.97K Hold
50
– – ﹤0.01% 201
2023
Q3 		$5.17K Hold
50
– – ﹤0.01% 202
2023
Q2 		$6.08K Hold
50
– – ﹤0.01% 196
2023
Q1 		$7.68K Hold
50
– – ﹤0.01% 197
2022
Q4 		$8.98K Buy
+50
New +$8.18K ﹤0.01% 195

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return